フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
- Dublin, Ireland and Boston, Massachusetts-based biopharmaceutical firm focused on rare diseases - Shares delisted fr ...
FTSE Russell 06 January 2022 Amryt Pharma (UK): Constituent Deletion Changes in FTSE UK Index Series 06 January 2022 Subject to the expected...
T Amryt Pharma plc - Key Dates for AIM Delisting DUBLIN, Ireland, and Boston MA, January 6, 2022, Amryt Pharma plc (Nasdaq: AMYT, AIM: AMYT...
T The Lancet Diabetes & Endocrinology Publishes Positive Results for the MPOWERED Phase 3 Trial for Mycapssa(R) (oral octreotide) in...
T Total Voting Rights DUBLIN, Ireland, and Boston MA, January 4, 2022, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...
T Total Voting Rights DUBLIN, Ireland, and Boston MA, December 1, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...
T Amryt Pharma plc Director/PDMR Shareholding The following notification is made in accordance with the requirements of the EU Market Abuse...
T Amryt Provides Update on Regulatory Review Process for Oleogel-S10 FDA PDUFA goal date extended by three months to February 28, 2022 EMA CHMP...
T THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 WHICH FORMS PART OF...
The following is a round-up of updates by London-listed companies not separately reported by Alliance News: --------- ...
T Amryt Reports Strong Q3 2021 Results 14.6% YoY revenue growth in Q3 to $56.5M 21.5% growth in metreleptin revenues YoY to $36.3M in Q3; 51.6...
T Total Voting Rights DUBLIN, Ireland, and Boston MA, November 1, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...
T Amryt to Report Q3 2021 Results and Host Conference Call & Webcast on November 3 DUBLIN, Ireland, and Boston MA, October 20, 2021, Amryt...
T Amryt Announces New Patents for Oleogel-S10 and Mycapssa(R) DUBLIN, Ireland, and Boston MA, October 19, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a...
T Total Voting Rights DUBLIN, Ireland, and Boston MA, October 1, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約